Evaluation of the Effects of Galantamine on Cardiac Function in Elderly Patients With Alzheimer's Disease
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, cilt.8, sa.5, ss.454-459, 2010 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8 Sayı: 5
- Basım Tarihi: 2010
- Doi Numarası: 10.1016/j.amjopharm.2010.09.001
- Dergi Adı: AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.454-459
- Anahtar Kelimeler: galantamine, elderly, Alzheimer's disease, electrocardiography
- Dokuz Eylül Üniversitesi Adresli: Hayır
Özet
Background: Galantamine, a cholinesterase inhibitor, is used as a first-line drug in the treatment of Alzheimer's disease (AD). However, it may have vagotonic effects, which may cause bradycardia and/or heart block in patients with or without a history of cardiac disease.